Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM38T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,509
Award facts
- Contract value 100% obligated
- $20,509.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $20,509.03 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulation. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at $999.9 million and extending through December 31, 2031, serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The contract award was not set aside and was competitively awarded through the open marketplace.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to efficiently fulfill government requirements for specialty medications and medical commodities across multiple therapeutic domains. This delivery order for Cosentyx, an immunosuppressant medication used to treat autoimmune conditions, exemplifies the company's role in supplying specialized pharmaceutical products essential to military treatment facilities and federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM38T?
SPE2DR26FM38T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FM38T worth?
The government has obligated $20,509 on SPE2DR26FM38T.
Is contract SPE2DR26FM38T an order under another contract?
Yes. SPE2DR26FM38T is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM38T competed?
The extent of competition for SPE2DR26FM38T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award